Alnylam Pharmaceuticals | ALNY - Azione

Prezzo Delle Azioni
295.59
Cambio Giornaliero
-6.52 -2.16%
Mensile
-6.49%
Annuale
12.29%
Q2 Previsione
299.00




Azione Cambiamento Data
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 10.05M 422K 2025-12
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12